Funding for this research was provided by:
the Blood Disease Research Foundation
the Competitive Research Funding of the Tampere University Hospital (9L114, 9N084)
the EVO funds of the Tampere University Hospital
the Emil Aaltonen Foundation
the Finnish Association of Hematology
the Finnish Cancer Foundation
the Finnish Cultural Foundation
the Finnish Cultural Foundation Pirkanmaa Regional Fund
the Finnish Medical Foundation
the Foundation for Pediatric Research
the Päivikki and Sakari Sohlberg Foundation
the Scientific Foundation of the City of Tampere
the Väre Foundation for Pediatric Cancer